IRCT201211211556N47已完成2 期
raloxifene as an add-on therapy in men with chronic schizophrenia: a randomized double blind and placebo controlled trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- Male
入选标准
- •Inclusion Criteria:1-Diagnosis of Schizophrenia based on DSM- IV criteria;2- Minimum Score of 60 on Positive and Negative Scale 3- Age between 18-55;4-male sex 5- chronic Schizophrenia- duration of the disorder more than 2 years; ; 6-Minimum score of 20 in negative suscore
排除标准
- •1-any other mental disorder on axis I; 2-Any serious medical or neurological problem; 3- IQ less than 70;4- Substance dependence during the last 6 months(except for nicotine and caffeine) 5-receiving oral antipsychotic medications during the last week or receiving any depot antipsychotic medication during the last month; ;6-receiving ECT during the last 14 days, 7-Endocrine abnormality; 8-hepatic and renal disease 9- history of thrombosis and embolism 10 history of abnormal bleeding 11- CVA
研究者
相似试验
已完成
2 期
Cilostazol in the treatment of schizophreniaschizophreniaIRCT201407151556N61Tehran University of Medical Sciences50
进行中（未招募）
1 期
Raloxifene in patients with a schizophrenia spectrum disorderEUCTR2015-004483-11-BEniversity Medical Center Utrecht154
进行中（未招募）
1 期
Raloxifene in patients with a schizophrenia spectrum disorderEUCTR2015-004483-11-NLniversity Medical Center Utrecht154
已完成
3 期
Raloxifene augmentation in patients with a schizophrenia spectrum disorder to reduce symptoms and improve cognitioschizophreniaschizoaffective disorderNL-OMON55630Psychiatrie95
已完成
2 期
Celecoxib in the treatment of obsessive-compulsive disorderObsessive- Cumpulsive Disorder.Obsessive-compulsive disorderIRCT201312181556N56Tehran University of Medical Sciences50